🔎 Trials Near Me

Početna › Debljina › Texas › Amarillo

Kliničke studije za Debljina u gradu Amarillo, TX

10 studija za Debljina traži sudionike na lokacijama u gradu Amarillo i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

U tijeku regrutacijaFaza 2
  • Amarillo Medical Specialists /ID# 282380, Amarillo
Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07752979

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

U tijeku regrutacijaFaza 3
  • Amarillo Medical Specialists, Amarillo
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

U tijeku regrutacijaFaza 3
  • Amarillo Med Spec LLP, Amarillo
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07668414

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

U tijeku regrutacijaFaza 3
  • Amarillo Medical Specialists, Amarillo
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07339423

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

U tijeku regrutacijaFaza 3
  • PharmaTex Research, LLC, Amarillo
Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

U tijeku regrutacijaFaza 3
  • PharmaTex Research, LLC, Amarillo
Od 18 do 99 godina · Oba spola · Ažurirano 16. ruj 2026. · NCT07037459

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

U tijeku regrutacijaFaza 3
  • Kailera Clinical Site, Amarillo
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

U tijeku regrutacijaFaza 3
  • Kailera Clinical Site, Amarillo
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT07284875

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

U tijeku regrutacijaFaza 3
  • PharmaTex Research, LLC, Amarillo
Od 18 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT07567001

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

U tijeku regrutacijaFaza 1
  • Amarillo Medical Specialists, Amarillo
Od 18 godina i više · Oba spola · Ažurirano 25. lip 2026. · NCT07607587

Studije za Debljina u drugim gradovima

Ostale studije u gradu Amarillo

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.